CANFNYSE American

Can-Fite BioPharma Ltd.

3.32−0.90%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tier
Alert levelinsufficient_liquidity

Tier and alert level are a summary. Unlock CANF to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

−3.77%, downReturn · 1w
+5.40%, upReturn · 1m
−0.90%, downReturn · 3m
−74.46%, downReturn · 1y
−75.59%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 49.

RSI (14)49.18Neutral
MACD / signal0.03 / 0.04, caution readingBelow signal line
SMA 503.29, favorable readingPrice above
SMA 2004.07, caution readingPrice below
EMA 203.35, caution readingPrice below
ADX (14)36.71Trending
+DI / −DI21.37 / 13.89, favorable reading+DI leading
ATR (14)0.18, flagged reading5.3% of price — elevated daily swings
Stochastic %K28.21Mid-range
Bollinger bands (20)3.08 – 3.60Inside bands
ROC (10)0.30, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth falling, caution impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking CANF reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock CANF: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get CANF + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock CANF